Bill Identity Ltd

0.068

+0.000

Volume:- -

Turnover:- -

Market Cap:16.79M

PE:-0.88

High:0.068

Open:0.068

Low:0.068

Close:0.068

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

GlobeNewswire

·

30 Jan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BID.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BID.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BID.AU\",,,,,undefined,":{"symbol":"BID.AU","market":"AU","secType":"STK","nameCN":"Bill Identity Ltd","latestPrice":0.068,"timestamp":1745380764111,"preClose":0.068,"halted":0,"volume":0,"delay":0,"nameEN":"Bill Identity Ltd","floatShares":170275144,"shares":246958356,"eps":-0.077345,"marketStatus":"Trading","change":0,"latestTime":"04-23 13:59:24 AEST","open":0.068,"high":0.068,"low":0.068,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.077345,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745388000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.068,"openAndCloseTimeList":[[1745366400000,1745388000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BID.AU\",,,,,undefined,":{"symbol":"BID.AU","floatShares":170275144,"roa":"-25.45%","roe":"-53.50%","lyrEps":-0.077317,"shares":246958356,"dividePrice":0,"high":0.068,"amplitude":0,"preClose":0.068,"low":0.068,"week52Low":0.068,"pbRate":"0.87","psRate":"1.12","week52High":0.068,"institutionHeld":0,"latestPrice":0.068,"eps":-0.077345,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.077345,"open":0.068,"prevYearClose":0.068,"prevWeekClose":0.068,"prevMonthClose":0.068,"prevQuarterClose":0.068,"fiveDayClose":0.068,"twentyDayClose":0.068,"sixtyDayClose":0.068},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BID.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BID.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507647737","title":"Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2507647737","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507647737?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:35","pubTimestamp":1738240500,"startTime":"0","endTime":"0","summary":"– Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –。– Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale –。– Key MRI Biomarker Shows Iron Stabilization in MSA Affected Brain Regions –。– ATH434 Demonstrated a Favorable Safety Profile –。– Webcast Held Yesterday with Access to the Recording Below –。“We are thrilled that ATH434 has demonstrated significant slowing of clinical progression and an excellent safety profile in this rare, rapidly progressive disease,” said David Stamler, M.D., Chief Executive Officer of Alterity. “Currently, there are no approved treatments that slow the progression of MSA and these results show that ATH434’s targeted iron engagement may truly have a disease modifying effect. The fact that we achieved statistical significance on the UMSARS is extremely meaningful because it assesses the functional areas affected in MSA and is the endpoint needed to support drug approval by the U.S. Food and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alterity-therapeutics-announces-positive-ath434-123500870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU0053671581.USD","AE","BK7067","LENZ","ATHE","LU0728928796.USD","MSA","LU2125909759.SGD","BID.AU","LU0757428866.USD","ATH.AU","LU1923622291.USD","BK4139","LU2211815571.USD","LU1815336091.USD","BK4138","LU2125909916.SGD","BK7016","BK4143"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BID.AU\",params:#limit:5,,,undefined,":[{"date":"2022-02-24","symbol":"BID.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1645657200000,"name":null,"time":"","dateTimestamp":1645621200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BID.AU\",market:\"AU\",,,undefined,":[]}}